December 2016

FDA and OHRP Issue Final Guidance on the Use of Electronic Informed Consent. The FDA and Office for Human Research Protections (OHRP) published final guidance - “Use of Electronic Informed Consent in Clinical Investigations--Questions and Answers” - aimed at providing answers to commonly asked questions about using electronic systems and processes that may employ multiple electronic media to obtain informed consent for both HHS-regulated human subject research and FDA-regulated clinical investigations of medical products, including human drug and biological products, medical devices, and combinations thereof. 
 
HHS take steps to provide more information about clinical trials to the public. In an effort to make information about clinical trials widely available to the public, the U.S. Department of Health and Human Services issued a final rule that outlines requirements for registering certain clinical trials and submitting summary results information to ClinicalTrials.gov.
 
Israeli pharmaceutical market set to reach $2.12B by 2020. The Israeli pharmaceutical market is set to rise from $1.75 billion in 2015 to around $2.12 billion by 2020, representing a compound annual growth rate of 3.9%, according to research and consulting firm GlobalData.
 
Rising trends in biotech oncology in Israel. In recent years, there has been a big change in the concept of diagnosing and treating cancer. Scientists and doctors have come to understand that the pathology is the reduction of the anticancer activity in the immune system. In accordance with this new raising concept, modern oncology has set itself two new fundamentals objectives: early detection of the decline of anticancer activity of the immune system and strengthening and restoration of the anticancer activity of the immune system so it self-destroys cancer cells.
 
Intel uses Big Data to create a groundbreaking change our health. Healthcare Group Director of Big Data Analytics division of Intel said at the "Mind the Data" of Calcalist newspapaer that "we have established a division of 150 engineers, most of them resides in Israel, which develops solutions for Big Data and Machine Running bounce symptoms of patients" (Hebrew).
 
"People are waiting for drugs and they are not getting them". "The clinical trials conducted in the world today have 125 million users, but few people know about," said Eze Vidra, Antidote Chief Innovation Officer, at the London "Mind The Tech" Calcalist conference. "Our product bridges the information gap between the trials sponsors and those who want to participate in them" (Hebrew).
 
Now live! Our new translations division of high quality certified medical and pharmaceutical translations. You are welcome to visit our new webpage: www.qt-translations.com